Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Regulation of the mutually exclusive exons 8a and 8 in the CaV1.2 calcium channel transcript by polypyrimidine tract-binding protein.

Tang ZZ, Sharma S, Zheng S, Chawla G, Nikolic J, Black DL.

J Biol Chem. 2011 Mar 25;286(12):10007-16. doi: 10.1074/jbc.M110.208116. Epub 2011 Jan 31.

2.

A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons.

Boutz PL, Stoilov P, Li Q, Lin CH, Chawla G, Ostrow K, Shiue L, Ares M Jr, Black DL.

Genes Dev. 2007 Jul 1;21(13):1636-52.

3.

Evidence that "brain-specific" FOX-1, FOX-2, and nPTB alternatively spliced isoforms are produced in the lens.

Bitel CL, Nathan R, Wong P, Kuppasani S, Matsushita M, Kanazawa H, Frederikse PH.

Curr Eye Res. 2011 Apr;36(4):321-7.

PMID:
21714144
4.

MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development.

Boutz PL, Chawla G, Stoilov P, Black DL.

Genes Dev. 2007 Jan 1;21(1):71-84.

5.

Developmental control of CaV1.2 L-type calcium channel splicing by Fox proteins.

Tang ZZ, Zheng S, Nikolic J, Black DL.

Mol Cell Biol. 2009 Sep;29(17):4757-65. doi: 10.1128/MCB.00608-09. Epub 2009 Jun 29.

7.
8.

Alternative splicing of brain-specific PTB defines a tissue-specific isoform pattern that predicts distinct functional roles.

Rahman L, Bliskovski V, Reinhold W, Zajac-Kaye M.

Genomics. 2002 Sep;80(3):245-9.

PMID:
12213192
9.

HuB/C/D, nPTB, REST4, and miR-124 regulators of neuronal cell identity are also utilized in the lens.

Bitel CL, Perrone-Bizzozero NI, Frederikse PH.

Mol Vis. 2010 Nov 4;16:2301-16.

10.

RBM4 down-regulates PTB and antagonizes its activity in muscle cell-specific alternative splicing.

Lin JC, Tarn WY.

J Cell Biol. 2011 May 2;193(3):509-20. doi: 10.1083/jcb.201007131. Epub 2011 Apr 25.

11.

Alternative splicing of neurexins: a role for neuronal polypyrimidine tract binding protein.

Resnick M, Segall A, G GR, Lupowitz Z, Zisapel N.

Neurosci Lett. 2008 Jul 18;439(3):235-40. doi: 10.1016/j.neulet.2008.05.034. Epub 2008 May 16.

PMID:
18534753
12.

Exon repression by polypyrimidine tract binding protein.

Amir-Ahmady B, Boutz PL, Markovtsov V, Phillips ML, Black DL.

RNA. 2005 May;11(5):699-716.

13.
14.
16.

Suggestive evidence on the involvement of polypyrimidine-tract binding protein in regulating alternative splicing of MAP/microtubule affinity-regulating kinase 4 in glioma.

Fontana L, Rovina D, Novielli C, Maffioli E, Tedeschi G, Magnani I, Larizza L.

Cancer Lett. 2015 Apr 1;359(1):87-96. doi: 10.1016/j.canlet.2014.12.049. Epub 2015 Jan 8.

PMID:
25578778
17.
18.

Polypyrimidine tract-binding protein represses splicing of a fibroblast growth factor receptor-2 gene alternative exon through exon sequences.

Le Guiner C, Plet A, Galiana D, Gesnel MC, Del Gatto-Konczak F, Breathnach R.

J Biol Chem. 2001 Nov 23;276(47):43677-87. Epub 2001 Sep 13.

19.

The PTB interacting protein raver1 regulates alpha-tropomyosin alternative splicing.

Gromak N, Rideau A, Southby J, Scadden AD, Gooding C, Hüttelmaier S, Singer RH, Smith CW.

EMBO J. 2003 Dec 1;22(23):6356-64.

20.

Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations.

Splawski I, Timothy KW, Decher N, Kumar P, Sachse FB, Beggs AH, Sanguinetti MC, Keating MT.

Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8089-96; discussion 8086-8. Epub 2005 Apr 29.

Supplemental Content

Support Center